I’m not familiar with the protocol.
Is it utterly dissociated from the company ? If there was no great benefit being observed full stop then its irrelevant which subject receives the placebo or which receives the application. Would progress be revealed in even the slightest manner to the company?
I’m genuinely curious as I’m placing a lot of faith in the outcome of these trials and we all know that faith can be tested !
Are these protocols “ policed “ as heavily as the rest of the ASX ( cue laughter ) ?
I’m not familiar with the protocol. Is it utterly dissociated...
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.0¢ | $230.9K | 653.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 89180 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 138744 | 8 |
View Market Depth
| Last trade - 10.50am 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
